IT1193128B - Composizione oleosa per farmaci antitumorali - Google Patents

Composizione oleosa per farmaci antitumorali

Info

Publication number
IT1193128B
IT1193128B IT67055/83A IT6705583A IT1193128B IT 1193128 B IT1193128 B IT 1193128B IT 67055/83 A IT67055/83 A IT 67055/83A IT 6705583 A IT6705583 A IT 6705583A IT 1193128 B IT1193128 B IT 1193128B
Authority
IT
Italy
Prior art keywords
oil composition
cancer drugs
drugs
cancer
oil
Prior art date
Application number
IT67055/83A
Other languages
English (en)
Italian (it)
Other versions
IT8367055A0 (it
Inventor
Kawata Hiroitsu
Ohmura Tadayoshi
Hasumi Shunji
Konno Yutaka
Aruga Masayoshi
Tashiro Seiki
Konno Toshimitsu
Iwai Ken
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP799782A external-priority patent/JPS58124714A/ja
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of IT8367055A0 publication Critical patent/IT8367055A0/it
Application granted granted Critical
Publication of IT1193128B publication Critical patent/IT1193128B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT67055/83A 1982-01-20 1983-01-19 Composizione oleosa per farmaci antitumorali IT1193128B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP799782A JPS58124714A (ja) 1982-01-20 1982-01-20 抗腫瘍物質の油性組成物
JP21504982 1982-12-08

Publications (2)

Publication Number Publication Date
IT8367055A0 IT8367055A0 (it) 1983-01-19
IT1193128B true IT1193128B (it) 1988-06-02

Family

ID=26342413

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67055/83A IT1193128B (it) 1982-01-20 1983-01-19 Composizione oleosa per farmaci antitumorali

Country Status (6)

Country Link
US (1) US4578391A (enExample)
KR (1) KR900005044B1 (enExample)
DE (1) DE3301638A1 (enExample)
FR (1) FR2519864B1 (enExample)
GB (1) GB2114885B (enExample)
IT (1) IT1193128B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028916A (ja) * 1983-07-13 1985-02-14 Yamanouchi Pharmaceut Co Ltd アクラルビシンまたはその塩酸塩の油性組成物
DD286971A5 (de) * 1985-08-02 1991-02-14 Merz U. Co. Gmbh U. Co.,De Antivirale und antitumor-zusammensetzung, verfahren zu deren herstellung und deren verwendung
US5389366A (en) * 1986-09-19 1995-02-14 Yamanouchi Pharmaceutical Co., Ltd. Neocarzinostatin derivative composition for oral administration
JP2556865B2 (ja) * 1986-09-19 1996-11-27 山之内製薬株式会社 ネオカルチノスタチン誘導体の非注射投与用組成物
WO1988006457A1 (fr) * 1987-03-04 1988-09-07 Nippon Hypox Laboratories Incorporated Composition medicinale contenant de l'albumine en tant que support et procede de preparation
JPH0794377B2 (ja) * 1987-07-22 1995-10-11 呉羽化学工業株式会社 エストラジオール誘導体を含有する注射剤
US5216011A (en) * 1989-09-01 1993-06-01 Bristol-Myers Squibb Co. Stable solutions of mitomycin c
US5496533A (en) * 1992-07-31 1996-03-05 Australian Nuclear Science & Technology Organisation Rhenium complexes
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
GB9422990D0 (en) * 1994-11-15 1995-01-04 Cortecs Ltd Immunogenic compositions
GB9424901D0 (en) * 1994-12-09 1995-02-08 Cortecs Ltd Sequestration Agents
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
GB9618420D0 (en) * 1996-09-04 1996-10-16 Scotia Holdings Plc Fatty acid treatment
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6117852A (en) * 1997-12-29 2000-09-12 National Science Council Boron-containing lipiodol for boron neutron capture therapy of hepatoma
IL131217A0 (en) * 1998-03-10 2001-01-28 Napro Biotherapeutics Inc Novel methods and compositions for delivery of taxanes
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
CN1243543C (zh) * 1998-07-20 2006-03-01 派普泰克有限公司 生物植入物配方
US8052982B2 (en) * 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
AU755443C (en) * 1998-07-20 2006-08-17 Virbac (Australia) Pty Limited Bioimplant formulation
US6463256B2 (en) * 1999-03-31 2002-10-08 Hewlett-Packard Company Duplexing module for printer
US6352718B1 (en) 1999-09-27 2002-03-05 American Cyanamid Company Vasopressin antagonist formulation and process
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US6831079B1 (en) 1999-09-27 2004-12-14 American Cyanamid Company Vasopressin agonist formulation and process
US6420358B1 (en) 1999-09-27 2002-07-16 American Cyanamid Company Vasopressin antagonist and diuretic combination
DE60111352T2 (de) * 2000-01-20 2006-05-04 Supratek Pharma, Inc., Montreal Podophyllotoxin-zusammensetzungen
AUPR644301A0 (en) * 2001-07-17 2001-08-09 Unisearch Limited Method and composition for treatment of cancer
US7094771B2 (en) * 2002-07-15 2006-08-22 National Tsing Hua University Pharmaceutical composition for boron neutron capture therapy containing triphenylboroxin
JP2006056781A (ja) * 2002-11-15 2006-03-02 Bioserentack Co Ltd 界面活性剤を含む固形化製剤
JP2006518380A (ja) * 2003-01-31 2006-08-10 スミスクライン・ビーチャム・コーポレイション 固体分散体組成物
US20070167422A1 (en) * 2006-01-18 2007-07-19 Yu Kwok S Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin
CN102260216A (zh) * 2010-05-28 2011-11-30 李茂全 5-氟尿嘧啶亲脂性衍生物碘化油
CN111298189A (zh) * 2018-12-11 2020-06-19 陈传果 一种易于推注的碘化油栓塞剂及其制备方法
CN109821055A (zh) * 2019-02-01 2019-05-31 厦门大学 一种药物-碘油溶剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5393M (enExample) * 1964-09-22 1967-10-30
US4104461A (en) * 1973-04-16 1978-08-01 Research Corporation 2,2'-Anhydro-β-D-arabinofuranosyl-5-fluorocytosine
US4011661A (en) * 1973-10-30 1977-03-15 Kyowa Hakko Kogyo Co., Ltd. Powdered emulsion product and method of production
JPS5439098A (en) * 1977-08-31 1979-03-24 Kyowa Hakko Kogyo Co Ltd Mitomycin c derivatives
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
JPS5686114A (en) * 1979-12-17 1981-07-13 Medeiseru Kenkyusho:Kk Pharmaceutical composition for suppository

Also Published As

Publication number Publication date
DE3301638C2 (enExample) 1989-08-24
DE3301638A1 (de) 1983-08-04
GB8301566D0 (en) 1983-02-23
FR2519864B1 (fr) 1985-09-27
GB2114885A (en) 1983-09-01
KR900005044B1 (ko) 1990-07-18
GB2114885B (en) 1985-09-04
IT8367055A0 (it) 1983-01-19
US4578391A (en) 1986-03-25
FR2519864A1 (fr) 1983-07-22
KR840003028A (ko) 1984-08-13

Similar Documents

Publication Publication Date Title
IT1193128B (it) Composizione oleosa per farmaci antitumorali
IT1169771B (it) Composizione per agenti antitumorali
NO831186L (no) Fortilsetning for droevtyggere
FR2547727B1 (fr) Compositions pharmaceutiques
NL190787C (nl) Oliesamenstelling.
FI831534L (fi) Oxikam-derivat innehaollande farmaceutiska kompositioner och deras framstaellningsfoerfarande
IT1162879B (it) Composizioni farmaceutiche
BE885527A (fr) Compositions pharmaceutiques pour nutrition parenterale
DE3688892D1 (de) Schmieroelzusammensetzung.
FI860419A7 (fi) Voiteluöljyseos.
IT8347765A0 (it) Composti piridinici utili in composizioni farmaceutiche
DE3670651D1 (de) Schmieroelzusammensetzungen.
FR2527078B1 (fr) Compositions pharmaceutiques anti-ulceres
DE3676172D1 (de) Schmieroelzusammensetzung.
DK528883A (da) Diplatin anti-cancermiddel
OA07489A (fr) Composition pharmaceutique antihypertensive synergétique.
FI830462L (fi) Mjoeldrygealkaloider, foerfarande foer deras framstaellning och dessa foereningar innehaollande farmaceutiska kompositioner
IT1152486B (it) Composizione farmaceutica antiateromasica
IT8221553A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.
IT8223904A0 (it) Composizione farmaceutica iniettabile.
IT8220275A0 (it) Composizione farmaceutica antiulcera contenente antagonisti istaminici.
FR2521008B1 (fr) Nouvelles compositions pharmaceutiques a base de thioridazine
RO84641A2 (ro) Proteza pentru handicapatii auditivi
IT8049902A0 (it) Composizione farmaceutica
KR850001238U (ko) 투약용 약숫가락

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950131